1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Giaccari Andrea: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of SGLT2 Inhibition on Myocardial Insulin Sensitivity Dapagliflozin 10Mg Tab, Placebo - Type2 Diabetes Mellitus, Stable Coronary Artery Disease | Phase 3 | Completed | Giaccari Andrea | 25 | 2017-12-01 | 2026-05-08 |
dapagliflozin (1)
Italy (1)
Andrea Giaccari (1)
PMID 34037951, PMID 36057768, PMID 37883003, PMID 38115004, PMID 40887630
2016 (1)